Roger Pomerantz's Net Worth

Roger Pomerantz's net worth is estimated to be at least $18,431,898.94 as of 11/23/2024. CoreStreet's estimation of Roger Pomerantz's net worth is based on their sale of stock and current holding of stock.

Roger Pomerantz is Insider at Seres Therapeutics Inc. They have executed at least 19 trades of stock as per SEC Form 4 filings. Their most recent trade was for 12,518 units of MCRB stock on 09/06/2018. Their biggest sale was on 04/04/2016 when they sold 135,788 units of Seres Therapeutics Inc stock for $3,693,433.60. They typically trade 9 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $18,431,898.94
Most recent insider trade:
  • Sept. 6, 2018

Roger Pomerantz's Insider Trading History

Seres Therapeutics IncTitleAmountPriceTypeTotal Value
Sept. 6, 2018
Insider12,518$9.10Sell$113,913.80
July 10, 2018
Insider32,336$9.12Sell$294,904.32
July 6, 2018
CEO15,366$9.14Sell$140,445.24
June 29, 2018
CEO4,496$9.10Sell$40,913.60
June 27, 2018
CEO16,991$9.03Sell$153,428.73
June 25, 2018
CEO26,752$9.21Sell$246,385.92
June 22, 2018
CEO40,057$9.36Sell$374,933.52
June 20, 2018
CEO26,492$9.33Sell$247,170.36
May 9, 2018
Insider233$9.00Sell$2,097.00
July 6, 2016
CEO88,211$29.45Sell$2,597,813.95
July 1, 2016
CEO56,789$29.81Sell$1,692,880.09
June 2, 2016
CEO74,049$32.52Sell$2,408,073.48
June 1, 2016
CEO70,951$30.51Sell$2,164,715.01
May 24, 2016
CEO9,801$30.00Sell$294,030.00
May 6, 2016
CEO8,507$24.31Sell$206,805.17
May 5, 2016
CEO59,325$26.13Sell$1,550,162.25
May 3, 2016
CEO67,367$28.70Sell$1,933,432.90
April 7, 2016
CEO9,212$30.00Sell$276,360.00
April 4, 2016
CEO135,788$27.20Sell$3,693,433.60